aluates Reports

$ 0.0

Automative

Global Kidney Cancer Market Research Report 2026

Published Date: 2026-03-30

Report Code: QYRE-Auto-38R2107

Global Kidney Cancer Market Insights Forecast to 2028

BUY CHAPTERS

Global Kidney Cancer Market Research Report 2026

Code: QYRE-Auto-38R2107

Report

2026-03-30

Pages:118

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck

Novartis

Bristol–Myers Squibb

Pfizer Inc

Roche

Amgen Inc

AVEO Pharmaceuticals

Bayer

Exelixis Inc

Eisai Co Ltd

Hikma Pharmaceuticals

Sun Pharmaceutical

Kidney Cancer Market Size

The global Kidney Cancer market was valued at US$ 12160 million in 2025 and is anticipated to reach US$ 18570 million by 2032, at a CAGR of 6.3% from 2026 to 2032.

Kidney Cancer Market

Kidney cancer therapy refers to a range of medical treatments aimed at managing or eradicating cancerous cells in the kidneys. These treatments include surgery (such as nephrectomy), targeted therapy, immunotherapy, radiation therapy, and, in some cases, chemotherapy. The choice of therapy depends on the type, stage, and progression of the cancer, as well as the patient’s overall health. The primary goals are to control the disease, prolong survival, and improve the patient’s quality of life.

Market Drivers for Kidney Cancer:

Increasing Prevalence of Kidney Cancer: Rising cases of kidney cancer worldwide, driven by aging populations and lifestyle-related factors, are boosting the demand for effective diagnostic and therapeutic solutions.

Advancements in Treatment Options: Innovations in targeted therapies, immunotherapies, and minimally invasive surgical techniques are improving patient outcomes, driving market growth.

Growing Awareness and Early Diagnosis: Enhanced awareness campaigns and improved screening technologies are leading to earlier detection, which increases the demand for treatments.

Supportive Government Policies and Funding: Increased investments in cancer research and supportive healthcare policies are fostering market expansion.

Market Challenges for Kidney Cancer:

High Treatment Costs: The expensive nature of advanced therapies, including immunotherapy and targeted drugs, limits accessibility for some patients, particularly in developing regions.

Side Effects and Resistance to Therapies: Adverse effects of treatments and the potential development of resistance to targeted drugs pose significant clinical and market challenges.

Limited Accessibility in Low-Income Regions: Inadequate healthcare infrastructure and limited access to advanced treatments in certain regions hinder market penetration.

Regulatory Hurdles: Stringent regulatory requirements for the approval of new drugs and therapies may delay market entry and development.

Global key players of Kidney Cancer include Pfizer, Exelixis, Bristol-Myers Squibb, Novartis, etc. Global top four manufacturers hold a share over 35%. North America has the largest number of Kidney cancer, holds a share of about 50%. In terms of product, targeted therapy is the largest segment, with a share over 45%. And in terms of application, the largest application is renal cell carcinoma, with a share of over 90%.

This report delivers a comprehensive overview of the global Kidney Cancer market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Kidney Cancer. The Kidney Cancer market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Kidney Cancer market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Kidney Cancer manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Kidney Cancer Market Report

Report Metric	Details
Report Name	Kidney Cancer Market
Accounted market size in 2025	US$ 12160 million
Forecasted market size in 2032	US$ 18570 million
CAGR	6.3%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Surgery Immunotherapy Targeted Therapy Other
Segment by Application	Renal Cell Carcinoma Renal Pelvis Cancer Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, Novartis, Bristol-Myers Squibb, Pfizer, Roche, Amgen, Aveo Pharmaceuticals, Bayer, Exelixis, Eisai, Hikma Pharmaceuticals, Sun Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Kidney Cancer companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Kidney Cancer Market growing?

Ans: The Kidney Cancer Market witnessing a CAGR of 6.3% during the forecast period 2026-2032.

What is the Kidney Cancer Market size in 2032?

Ans: The Kidney Cancer Market size in 2032 will be US$ 18570 million.

What is the market share of major companies in Kidney Cancer Market?

Ans: Global top four manufacturers hold a share over 35%.

What is the Kidney Cancer Market share by region?

Ans: North America has the largest number of Kidney cancer, holds a share of about 50%.

What is the Kidney Cancer Market share by type?

Ans: In terms of product, targeted therapy is the largest segment, with a share over 45%.

What is the Kidney Cancer Market share by application?

Ans: And in terms of application, the largest application is renal cell carcinoma, with a share of over 90%.

Who are the main players in the Kidney Cancer Market report?

Ans: The main players in the Kidney Cancer Market are Merck, Novartis, Bristol-Myers Squibb, Pfizer, Roche, Amgen, Aveo Pharmaceuticals, Bayer, Exelixis, Eisai, Hikma Pharmaceuticals, Sun Pharmaceutical

What are the Application segmentation covered in the Kidney Cancer Market report?

Ans: The Applications covered in the Kidney Cancer Market report are Renal Cell Carcinoma, Renal Pelvis Cancer, Other

What are the Type segmentation covered in the Kidney Cancer Market report?

Ans: The Types covered in the Kidney Cancer Market report are Surgery, Immunotherapy, Targeted Therapy, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Kidney Cancer Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Surgery

1.2.3 Immunotherapy

1.2.4 Targeted Therapy

1.2.5 Other

1.3 Market by Application

1.3.1 Global Kidney Cancer Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Renal Cell Carcinoma

1.3.3 Renal Pelvis Cancer

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Kidney Cancer Market Perspective (2021–2032)

2.2 Global Kidney Cancer Growth Trends by Region

2.2.1 Global Kidney Cancer Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Kidney Cancer Historic Market Size by Region (2021–2026)

2.2.3 Kidney Cancer Forecasted Market Size by Region (2027–2032)

2.3 Kidney Cancer Market Dynamics

2.3.1 Kidney Cancer Industry Trends

2.3.2 Kidney Cancer Market Drivers

2.3.3 Kidney Cancer Market Challenges

2.3.4 Kidney Cancer Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Kidney Cancer Players by Revenue

3.1.1 Global Top Kidney Cancer Players by Revenue (2021–2026)

3.1.2 Global Kidney Cancer Revenue Market Share by Players (2021–2026)

3.2 Global Top Kidney Cancer Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Kidney Cancer Revenue

3.4 Global Kidney Cancer Market Concentration Ratio

3.4.1 Global Kidney Cancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer Revenue in 2025

3.5 Global Key Players of Kidney Cancer Head Offices and Areas Served

3.6 Global Key Players of Kidney Cancer, Products and Applications

3.7 Global Key Players of Kidney Cancer, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Kidney Cancer Breakdown Data by Type

4.1 Global Kidney Cancer Historic Market Size by Type (2021–2026)

4.2 Global Kidney Cancer Forecasted Market Size by Type (2027–2032)

5 Kidney Cancer Breakdown Data by Application

5.1 Global Kidney Cancer Historic Market Size by Application (2021–2026)

5.2 Global Kidney Cancer Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Kidney Cancer Market Size (2021–2032)

6.2 North America Kidney Cancer Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Kidney Cancer Market Size by Country (2021–2026)

6.4 North America Kidney Cancer Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Kidney Cancer Market Size (2021–2032)

7.2 Europe Kidney Cancer Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Kidney Cancer Market Size by Country (2021–2026)

7.4 Europe Kidney Cancer Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Kidney Cancer Market Size (2021–2032)

8.2 Asia-Pacific Kidney Cancer Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Kidney Cancer Market Size by Region (2021–2026)

8.4 Asia-Pacific Kidney Cancer Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Kidney Cancer Market Size (2021–2032)

9.2 Latin America Kidney Cancer Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Kidney Cancer Market Size by Country (2021–2026)

9.4 Latin America Kidney Cancer Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Kidney Cancer Market Size (2021–2032)

10.2 Middle East & Africa Kidney Cancer Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Kidney Cancer Market Size by Country (2021–2026)

10.4 Middle East & Africa Kidney Cancer Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck

11.1.1 Merck Company Details

11.1.2 Merck Business Overview

11.1.3 Merck Kidney Cancer Introduction

11.1.4 Merck Revenue in Kidney Cancer Business (2021–2026)

11.1.5 Merck Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Kidney Cancer Introduction

11.2.4 Novartis Revenue in Kidney Cancer Business (2021–2026)

11.2.5 Novartis Recent Development

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Details

11.3.2 Bristol-Myers Squibb Business Overview

11.3.3 Bristol-Myers Squibb Kidney Cancer Introduction

11.3.4 Bristol-Myers Squibb Revenue in Kidney Cancer Business (2021–2026)

11.3.5 Bristol-Myers Squibb Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Kidney Cancer Introduction

11.4.4 Pfizer Revenue in Kidney Cancer Business (2021–2026)

11.4.5 Pfizer Recent Development

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Kidney Cancer Introduction

11.5.4 Roche Revenue in Kidney Cancer Business (2021–2026)

11.5.5 Roche Recent Development

11.6 Amgen

11.6.1 Amgen Company Details

11.6.2 Amgen Business Overview

11.6.3 Amgen Kidney Cancer Introduction

11.6.4 Amgen Revenue in Kidney Cancer Business (2021–2026)

11.6.5 Amgen Recent Development

11.7 Aveo Pharmaceuticals

11.7.1 Aveo Pharmaceuticals Company Details

11.7.2 Aveo Pharmaceuticals Business Overview

11.7.3 Aveo Pharmaceuticals Kidney Cancer Introduction

11.7.4 Aveo Pharmaceuticals Revenue in Kidney Cancer Business (2021–2026)

11.7.5 Aveo Pharmaceuticals Recent Development

11.8 Bayer

11.8.1 Bayer Company Details

11.8.2 Bayer Business Overview

11.8.3 Bayer Kidney Cancer Introduction

11.8.4 Bayer Revenue in Kidney Cancer Business (2021–2026)

11.8.5 Bayer Recent Development

11.9 Exelixis

11.9.1 Exelixis Company Details

11.9.2 Exelixis Business Overview

11.9.3 Exelixis Kidney Cancer Introduction

11.9.4 Exelixis Revenue in Kidney Cancer Business (2021–2026)

11.9.5 Exelixis Recent Development

11.10 Eisai

11.10.1 Eisai Company Details

11.10.2 Eisai Business Overview

11.10.3 Eisai Kidney Cancer Introduction

11.10.4 Eisai Revenue in Kidney Cancer Business (2021–2026)

11.10.5 Eisai Recent Development

11.11 Hikma Pharmaceuticals

11.11.1 Hikma Pharmaceuticals Company Details

11.11.2 Hikma Pharmaceuticals Business Overview

11.11.3 Hikma Pharmaceuticals Kidney Cancer Introduction

11.11.4 Hikma Pharmaceuticals Revenue in Kidney Cancer Business (2021–2026)

11.11.5 Hikma Pharmaceuticals Recent Development

11.12 Sun Pharmaceutical

11.12.1 Sun Pharmaceutical Company Details

11.12.2 Sun Pharmaceutical Business Overview

11.12.3 Sun Pharmaceutical Kidney Cancer Introduction

11.12.4 Sun Pharmaceutical Revenue in Kidney Cancer Business (2021–2026)

11.12.5 Sun Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Merck

Novartis

Bristol–Myers Squibb

Pfizer Inc

Roche

Amgen Inc

AVEO Pharmaceuticals

Bayer

Exelixis Inc

Eisai Co Ltd

Hikma Pharmaceuticals

Sun Pharmaceutical

List of Tables

Table 1. Global Kidney Cancer Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Surgery

Table 3. Key Players of Immunotherapy

Table 4. Key Players of Targeted Therapy

Table 5. Key Players of Other

Table 6. Global Kidney Cancer Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Kidney Cancer Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Kidney Cancer Market Size by Region (US$ Million), 2021–2026

Table 9. Global Kidney Cancer Market Share by Region (2021–2026)

Table 10. Global Kidney Cancer Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global Kidney Cancer Market Share by Region (2027–2032)

Table 12. Kidney Cancer Market Trends

Table 13. Kidney Cancer Market Drivers

Table 14. Kidney Cancer Market Challenges

Table 15. Kidney Cancer Market Restraints

Table 16. Global Kidney Cancer Revenue by Players (US$ Million), 2021–2026

Table 17. Global Kidney Cancer Market Share by Players (2021–2026)

Table 18. Global Top Kidney Cancer Players by Tier (Tier 1, Tier 2, and Tier 3), based on Kidney Cancer Revenue, 2025

Table 19. Ranking of Global Top Kidney Cancer Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by Kidney Cancer Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of Kidney Cancer, Headquarters and Area Served

Table 22. Global Key Players of Kidney Cancer, Products and Applications

Table 23. Global Key Players of Kidney Cancer, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global Kidney Cancer Market Size by Type (US$ Million), 2021–2026

Table 26. Global Kidney Cancer Revenue Market Share by Type (2021–2026)

Table 27. Global Kidney Cancer Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global Kidney Cancer Revenue Market Share by Type (2027–2032)

Table 29. Global Kidney Cancer Market Size by Application (US$ Million), 2021–2026

Table 30. Global Kidney Cancer Revenue Market Share by Application (2021–2026)

Table 31. Global Kidney Cancer Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global Kidney Cancer Revenue Market Share by Application (2027–2032)

Table 33. North America Kidney Cancer Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America Kidney Cancer Market Size by Country (US$ Million), 2021–2026

Table 35. North America Kidney Cancer Market Size by Country (US$ Million), 2027–2032

Table 36. Europe Kidney Cancer Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe Kidney Cancer Market Size by Country (US$ Million), 2021–2026

Table 38. Europe Kidney Cancer Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific Kidney Cancer Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific Kidney Cancer Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific Kidney Cancer Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America Kidney Cancer Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America Kidney Cancer Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America Kidney Cancer Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa Kidney Cancer Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa Kidney Cancer Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa Kidney Cancer Market Size by Country (US$ Million), 2027–2032

Table 48. Merck Company Details

Table 49. Merck Business Overview

Table 50. Merck Kidney Cancer Product

Table 51. Merck Revenue in Kidney Cancer Business (US$ Million), 2021–2026

Table 52. Merck Recent Development

Table 53. Novartis Company Details

Table 54. Novartis Business Overview

Table 55. Novartis Kidney Cancer Product

Table 56. Novartis Revenue in Kidney Cancer Business (US$ Million), 2021–2026

Table 57. Novartis Recent Development

Table 58. Bristol-Myers Squibb Company Details

Table 59. Bristol-Myers Squibb Business Overview

Table 60. Bristol-Myers Squibb Kidney Cancer Product

Table 61. Bristol-Myers Squibb Revenue in Kidney Cancer Business (US$ Million), 2021–2026

Table 62. Bristol-Myers Squibb Recent Development

Table 63. Pfizer Company Details

Table 64. Pfizer Business Overview

Table 65. Pfizer Kidney Cancer Product

Table 66. Pfizer Revenue in Kidney Cancer Business (US$ Million), 2021–2026

Table 67. Pfizer Recent Development

Table 68. Roche Company Details

Table 69. Roche Business Overview

Table 70. Roche Kidney Cancer Product

Table 71. Roche Revenue in Kidney Cancer Business (US$ Million), 2021–2026

Table 72. Roche Recent Development

Table 73. Amgen Company Details

Table 74. Amgen Business Overview

Table 75. Amgen Kidney Cancer Product

Table 76. Amgen Revenue in Kidney Cancer Business (US$ Million), 2021–2026

Table 77. Amgen Recent Development

Table 78. Aveo Pharmaceuticals Company Details

Table 79. Aveo Pharmaceuticals Business Overview

Table 80. Aveo Pharmaceuticals Kidney Cancer Product

Table 81. Aveo Pharmaceuticals Revenue in Kidney Cancer Business (US$ Million), 2021–2026

Table 82. Aveo Pharmaceuticals Recent Development

Table 83. Bayer Company Details

Table 84. Bayer Business Overview

Table 85. Bayer Kidney Cancer Product

Table 86. Bayer Revenue in Kidney Cancer Business (US$ Million), 2021–2026

Table 87. Bayer Recent Development

Table 88. Exelixis Company Details

Table 89. Exelixis Business Overview

Table 90. Exelixis Kidney Cancer Product

Table 91. Exelixis Revenue in Kidney Cancer Business (US$ Million), 2021–2026

Table 92. Exelixis Recent Development

Table 93. Eisai Company Details

Table 94. Eisai Business Overview

Table 95. Eisai Kidney Cancer Product

Table 96. Eisai Revenue in Kidney Cancer Business (US$ Million), 2021–2026

Table 97. Eisai Recent Development

Table 98. Hikma Pharmaceuticals Company Details

Table 99. Hikma Pharmaceuticals Business Overview

Table 100. Hikma Pharmaceuticals Kidney Cancer Product

Table 101. Hikma Pharmaceuticals Revenue in Kidney Cancer Business (US$ Million), 2021–2026

Table 102. Hikma Pharmaceuticals Recent Development

Table 103. Sun Pharmaceutical Company Details

Table 104. Sun Pharmaceutical Business Overview

Table 105. Sun Pharmaceutical Kidney Cancer Product

Table 106. Sun Pharmaceutical Revenue in Kidney Cancer Business (US$ Million), 2021–2026

Table 107. Sun Pharmaceutical Recent Development

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Kidney Cancer Picture

Figure 2. Global Kidney Cancer Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Kidney Cancer Market Share by Type: 2025 vs 2032

Figure 4. Surgery Features

Figure 5. Immunotherapy Features

Figure 6. Targeted Therapy Features

Figure 7. Other Features

Figure 8. Global Kidney Cancer Market Size by Application (US$ Million), 2021–2032

Figure 9. Global Kidney Cancer Market Share by Application: 2025 vs 2032

Figure 10. Renal Cell Carcinoma Case Studies

Figure 11. Renal Pelvis Cancer Case Studies

Figure 12. Other Case Studies

Figure 13. Kidney Cancer Report Years Considered

Figure 14. Global Kidney Cancer Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 15. Global Kidney Cancer Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Kidney Cancer Market Share by Region: 2025 vs 2032

Figure 17. Global Kidney Cancer Market Share by Players in 2025

Figure 18. Global Kidney Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Kidney Cancer Revenue in 2025

Figure 20. North America Kidney Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. North America Kidney Cancer Market Share by Country (2021–2032)

Figure 22. United States Kidney Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Canada Kidney Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Kidney Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Kidney Cancer Market Share by Country (2021–2032)

Figure 26. Germany Kidney Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. France Kidney Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. U.K. Kidney Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Italy Kidney Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Russia Kidney Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Ireland Kidney Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Kidney Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Kidney Cancer Market Share by Region (2021–2032)

Figure 34. China Kidney Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Japan Kidney Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. South Korea Kidney Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Southeast Asia Kidney Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. India Kidney Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Australia & New Zealand Kidney Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Kidney Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Kidney Cancer Market Share by Country (2021–2032)

Figure 42. Mexico Kidney Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Brazil Kidney Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Kidney Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Kidney Cancer Market Share by Country (2021–2032)

Figure 46. Israel Kidney Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Saudi Arabia Kidney Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. UAE Kidney Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Merck Revenue Growth Rate in Kidney Cancer Business (2021–2026)

Figure 50. Novartis Revenue Growth Rate in Kidney Cancer Business (2021–2026)

Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Kidney Cancer Business (2021–2026)

Figure 52. Pfizer Revenue Growth Rate in Kidney Cancer Business (2021–2026)

Figure 53. Roche Revenue Growth Rate in Kidney Cancer Business (2021–2026)

Figure 54. Amgen Revenue Growth Rate in Kidney Cancer Business (2021–2026)

Figure 55. Aveo Pharmaceuticals Revenue Growth Rate in Kidney Cancer Business (2021–2026)

Figure 56. Bayer Revenue Growth Rate in Kidney Cancer Business (2021–2026)

Figure 57. Exelixis Revenue Growth Rate in Kidney Cancer Business (2021–2026)

Figure 58. Eisai Revenue Growth Rate in Kidney Cancer Business (2021–2026)

Figure 59. Hikma Pharmaceuticals Revenue Growth Rate in Kidney Cancer Business (2021–2026)

Figure 60. Sun Pharmaceutical Revenue Growth Rate in Kidney Cancer Business (2021–2026)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Late Stage Chronic Kidney Disease Therapeutics Market Research Report 2024

Global Kidney Cancer Therapy Market Research Report 2024

Global Cancer Drug Therapy Market Insights Forecast to 2030

Global Kidney Cancer Therapeutics and Diagnostics Market Insights Forecast to 2030

Global Kidney Cancer Therapeutics Market Research Report 2025

Renal Cell Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Kidney Cancer Drugs Market Research Report 2024

Kidney Cancer Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Kidney Cancer or Renal Cancer Market Research Report 2024

Renal Cell Carcinoma Therapy Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Kidney Cancer Targeted Therapy Market Research Report 2025

Global Kidney Cancer and Renal Cell Carcinoma RCC Drugs Market Insights Forecast to 2030

Kidney Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Targeted Drug Market Research Report 2025

Global Cancer Immunosuppressant Treatment Market Research Report 2024

Global Renal Therapeutic Market Research Report 2025

Global Urological Cancer Therapeutics Drugs Market Research Report 2024

Global Oncology Targeted Therapy Market Research Report 2025

Genitourinary Cancers Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions